vs
CENTRUS ENERGY CORP（LEU）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
CENTRUS ENERGY CORP的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.9倍（$146.2M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -3.6%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-58.0M），过去两年CENTRUS ENERGY CORP的营收复合增速更高（82.9% vs 31.3%）
Centrus Energy Corp是美国能源企业，主营核电站所需核燃料供应，同时专注于离心技术的研发与落地推广，生产可应用于商业、政府场景及国家安全领域的浓缩铀产品。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
LEU vs PBYI — 直观对比
营收规模更大
LEU
是对方的1.9倍
$75.5M
营收增速更快
PBYI
高出31.3%
-3.6%
自由现金流更多
PBYI
多$72.4M
$-58.0M
两年增速更快
LEU
近两年复合增速
31.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $146.2M | $75.5M |
| 净利润 | — | — |
| 毛利率 | 23.9% | 69.3% |
| 营业利润率 | 8.8% | 22.7% |
| 净利率 | — | — |
| 营收同比 | -3.6% | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.52 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LEUPBYI
| Q4 25 | $146.2M | $75.5M | ||
| Q3 25 | $74.9M | $54.5M | ||
| Q2 25 | $154.5M | $52.4M | ||
| Q1 25 | $73.1M | $46.0M | ||
| Q4 24 | $151.6M | $59.1M | ||
| Q3 24 | $57.7M | $80.5M | ||
| Q2 24 | $189.0M | $47.1M | ||
| Q1 24 | $43.7M | $43.8M |
净利润LEUPBYI
| Q4 25 | — | — | ||
| Q3 25 | $3.9M | $8.8M | ||
| Q2 25 | $28.9M | $5.9M | ||
| Q1 25 | $27.2M | $3.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-5.0M | $20.3M | ||
| Q2 24 | $30.6M | $-4.5M | ||
| Q1 24 | $-6.1M | $-4.8M |
毛利率LEUPBYI
| Q4 25 | 23.9% | 69.3% | ||
| Q3 25 | -5.7% | 77.7% | ||
| Q2 25 | 34.9% | 76.5% | ||
| Q1 25 | 45.0% | 77.1% | ||
| Q4 24 | 40.8% | 76.4% | ||
| Q3 24 | 15.4% | 63.9% | ||
| Q2 24 | 19.3% | 77.4% | ||
| Q1 24 | 9.8% | 75.5% |
营业利润率LEUPBYI
| Q4 25 | 8.8% | 22.7% | ||
| Q3 25 | -22.2% | 17.6% | ||
| Q2 25 | 21.7% | 12.7% | ||
| Q1 25 | 28.0% | 8.7% | ||
| Q4 24 | 29.7% | 22.6% | ||
| Q3 24 | -13.2% | 27.4% | ||
| Q2 24 | 11.2% | -4.6% | ||
| Q1 24 | -24.3% | -5.3% |
净利率LEUPBYI
| Q4 25 | — | — | ||
| Q3 25 | 5.2% | 16.2% | ||
| Q2 25 | 18.7% | 11.2% | ||
| Q1 25 | 37.2% | 6.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | -8.7% | 25.2% | ||
| Q2 24 | 16.2% | -9.6% | ||
| Q1 24 | -14.0% | -11.0% |
每股收益（稀释后）LEUPBYI
| Q4 25 | $0.52 | $0.26 | ||
| Q3 25 | $0.19 | $0.17 | ||
| Q2 25 | $1.59 | $0.12 | ||
| Q1 25 | $1.60 | $0.06 | ||
| Q4 24 | $3.26 | $0.40 | ||
| Q3 24 | $-0.30 | $0.41 | ||
| Q2 24 | $1.89 | $-0.09 | ||
| Q1 24 | $-0.38 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.0B | $97.5M |
| 总债务越低越好 | $1.2B | $22.7M |
| 股东权益账面价值 | $765.1M | $130.3M |
| 总资产 | $2.4B | $216.3M |
| 负债/权益比越低杠杆越低 | 1.54× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资LEUPBYI
| Q4 25 | $2.0B | $97.5M | ||
| Q3 25 | $1.6B | $94.4M | ||
| Q2 25 | $833.0M | $96.0M | ||
| Q1 25 | $653.0M | $93.2M | ||
| Q4 24 | $671.4M | $101.0M | ||
| Q3 24 | $194.3M | $96.7M | ||
| Q2 24 | $227.0M | $96.8M | ||
| Q1 24 | $209.3M | $107.2M |
总债务LEUPBYI
| Q4 25 | $1.2B | $22.7M | ||
| Q3 25 | $1.2B | $34.0M | ||
| Q2 25 | $390.0M | $45.3M | ||
| Q1 25 | $389.5M | $56.7M | ||
| Q4 24 | $472.5M | $68.0M | ||
| Q3 24 | $83.5M | $79.3M | ||
| Q2 24 | $86.5M | $90.7M | ||
| Q1 24 | $86.5M | $102.0M |
股东权益LEUPBYI
| Q4 25 | $765.1M | $130.3M | ||
| Q3 25 | $363.1M | $115.3M | ||
| Q2 25 | $359.1M | $104.7M | ||
| Q1 25 | $213.9M | $97.1M | ||
| Q4 24 | $161.4M | $92.1M | ||
| Q3 24 | $76.4M | $71.1M | ||
| Q2 24 | $76.6M | $48.5M | ||
| Q1 24 | $33.8M | $51.0M |
总资产LEUPBYI
| Q4 25 | $2.4B | $216.3M | ||
| Q3 25 | $2.2B | $202.9M | ||
| Q2 25 | $1.3B | $194.9M | ||
| Q1 25 | $1.3B | $196.2M | ||
| Q4 24 | $1.1B | $213.3M | ||
| Q3 24 | $591.0M | $220.7M | ||
| Q2 24 | $668.2M | $205.0M | ||
| Q1 24 | $750.0M | $214.1M |
负债/权益比LEUPBYI
| Q4 25 | 1.54× | 0.17× | ||
| Q3 25 | 3.23× | 0.30× | ||
| Q2 25 | 1.09× | 0.43× | ||
| Q1 25 | 1.82× | 0.58× | ||
| Q4 24 | 2.93× | 0.74× | ||
| Q3 24 | 1.09× | 1.12× | ||
| Q2 24 | 1.13× | 1.87× | ||
| Q1 24 | 2.56× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-48.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-58.0M | $14.4M |
| 自由现金流率自由现金流/营收 | -39.7% | 19.1% |
| 资本支出强度资本支出/营收 | 6.6% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $31.3M | $41.7M |
8季度趋势，按日历期对齐
经营现金流LEUPBYI
| Q4 25 | $-48.4M | $14.4M | ||
| Q3 25 | $10.1M | $9.7M | ||
| Q2 25 | $52.8M | $14.1M | ||
| Q1 25 | $36.5M | $3.6M | ||
| Q4 24 | $57.9M | $15.6M | ||
| Q3 24 | $-33.2M | $11.0M | ||
| Q2 24 | $7.0M | $1.0M | ||
| Q1 24 | $5.3M | $11.2M |
自由现金流LEUPBYI
| Q4 25 | $-58.0M | $14.4M | ||
| Q3 25 | $5.7M | $9.7M | ||
| Q2 25 | $49.2M | $14.1M | ||
| Q1 25 | $34.4M | $3.6M | ||
| Q4 24 | $57.2M | $15.6M | ||
| Q3 24 | $-34.2M | $11.0M | ||
| Q2 24 | $6.1M | $1.0M | ||
| Q1 24 | $3.8M | — |
自由现金流率LEUPBYI
| Q4 25 | -39.7% | 19.1% | ||
| Q3 25 | 7.6% | 17.7% | ||
| Q2 25 | 31.8% | 26.8% | ||
| Q1 25 | 47.1% | 7.7% | ||
| Q4 24 | 37.7% | 26.4% | ||
| Q3 24 | -59.3% | 13.7% | ||
| Q2 24 | 3.2% | 2.1% | ||
| Q1 24 | 8.7% | — |
资本支出强度LEUPBYI
| Q4 25 | 6.6% | 0.0% | ||
| Q3 25 | 5.9% | 0.0% | ||
| Q2 25 | 2.3% | 0.0% | ||
| Q1 25 | 2.9% | 0.1% | ||
| Q4 24 | 0.5% | 0.0% | ||
| Q3 24 | 1.7% | 0.0% | ||
| Q2 24 | 0.5% | 0.0% | ||
| Q1 24 | 3.4% | 0.0% |
现金转化率LEUPBYI
| Q4 25 | — | — | ||
| Q3 25 | 2.59× | 1.10× | ||
| Q2 25 | 1.83× | 2.41× | ||
| Q1 25 | 1.34× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | 0.23× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LEU
| Separative Work Units | $111.0M | 76% |
| Services | $21.8M | 15% |
| Other | $13.4M | 9% |
PBYI
暂无分部数据
